still helping CureVac make Vaccines against covid-19 and can expand capacity to support other vaccine manufacturers, chief financial officer Harry Kirsch told reporters on Wednesday.
“We’ve started production as planned. We’re planning to deliver 50 million doses of the drug this year,” Kirsch said of the CureVac deal when asked if it could instead provide the technology for free. capacity for others after CureVac said last month its COVID-19. hit only 48% effective.
Swiss drugmaker Novartis also supports Pfizer and BioNTech in making COVID-19 vaccines and can increase production for them or others if needed, he said.
https://economictimes.indiatimes.com/news/international/business/novartis-set-to-deliver-50-mn-curevac-covid-19-vaccines-this-year/articleshow/84608286.cms | CureVac: Novartis expects to deliver 50 million CureVac COVID-19 vaccines this year
